Research services

Opportunity for AIRC-Funded Researchers to benefit of Genomics Services at Cogentech 

Fondazione AIRC supports cancer research by facilitating access to advanced scientific and technological services. 

In this framework, AIRC has established a collaboration with Cogentech, a Benefit Corporation controlled by IFOM — the AIRC Foundation Institute of Molecular Oncology — to offer AIRC-funded researchers (grantees and fellows) access to Genomics services under predefined conditions and discounted pricing. 

Cogentech provides genomics services to the broader research community using state-of-the-art instrumentation, including the NovaSeq6000 DX (active) and NovaSeq X Plus (active on January 2027) sequencing platforms. Dedicated terms are available for AIRC-funded investigators. 

Access the services 

AIRC AIRC funded researchers can access the Cogentech platform via the dedicated link below and submit their requests directly. Service provision, timelines, and deliverables are managed entirely by Cogentech. 

Role of AIRC 

AIRC acts solely as a facilitator of access to the services: 

• AIRC does not provide or manage the services 

• All services are delivered independently by Cogentech 

• Any contractual relationship is directly between the researcher and Cogentech 

Cogentech is solely responsible for the execution, quality, and compliance of the services provided.